340B’s Transparency Problem Is a Taxpayer Problem
The federal 340B Drug Pricing Program was created in 1992 with a straightforward mission: help safety-net hospitals and clinics stretch limited resources to serve low-income and uninsured patients. Three[…]
CAP Policy Fellow Patrick Kilbride’s Op-Ed in RealClearHealth on How Patents Drive Continued Medical Innovation
Center for American Principles Policy Fellow Patrick Kilbride recently published an Op-Ed in RealClearHealth on the critical role strong patent protections play in encouraging the development of new and[…]